Continuing Education  » Evidence Based / Specialty Updates  » Long-term Use of Oclacitinib in Dogs

Long-term Use of Oclacitinib in Dogs

CE Event Information

  • Description:
    Relief from pruritus associated with allergic skin disease can be challenging and may include the use of medicated shampoos, and antipruritic drug monotherapy or in combination with allergen-specific immunotherapy.

    Oclacitinib is a Janus kinase inhibitor and is approved for use in dogs for managing pruritus and inflammation associated with allergic dermatitis. Until recently, however, little was known about the effects and safety of long-term use of this immunomodulatory drug in dogs with allergic skin disease.

    The subject of this week's Evidence Based Update is the use of oclacitinib in dogs with allergic skin disease. Discussion includes:

    - The effects and safety of oclacitinib with long-term use in dogs
    - Recommended dosing of oclacitinib in dogs
    - Expected side effects / tolerability
    - Recommended monitoring of patients
    - Impact on the quality of life of dogs with allergic skin disease

    Running time:  15 mins
    Read more on this topic:
  • Sponsor: Zoetis
  • Presenter(s): Elisabeth Zenger, DVM, PhD, DACVIM (SAIM)
  • Fee (Basic Membership): $9.95

Featured Publications

The following journal articles or textbook chapters have been selected as Supplements to this event. You can elect to purchase them as part of a discounted seminar package fee.
Prepaid CE Subscribers will be assessed a supplement fee for articles purchased.

  • Small Animal Dermatology (3rd ed), 2011, Chapter 7, pp 175-226. Member Fee: $5.95 - Login to purchase and download
  • Practical Cytology For Inflammatory Skin Diseases

    Clin Techniques in Sm Anim Practice - Vol 21 (3), August 2006, pp 117-127. Authors: Colleen Mendelsohn, Wayne Rosenkrantz, Craig E. Griffin....  more
  • Alternative Therapies in Veterinary Dermatology

    Veterinary Clinics of North America: Small Animal Practice, Vol 43(1), January 2013, Pages 189-204. Authors: Jeanne B. Budgin, Molly J. Flah...  more